Search

Wen S Liu

from New York, NY
Age ~58
Get Report
Also known as:
Liu Wen
Phone and address:
75 La Salle St APT 5E, New York, NY 10027
(646) 897-3589
Related to:
Yigun LiLi Li, 54Jian Wan, 63Cheng Y Yan, 63Bai Yan, 53Minxing Li Xing, 67Michelle X Huang, 38Lisa Li, 47Ronghua Liu, 44Xing J LiTian K Liu, 58Lu LiuYan Hong Liu, 52Jie Huang, 65Jian Huang, 65Alvin Law, 51Mu LiuCatherine Yuan, 29Li Yan, 61Kuangcheng Liu, 69Zhen Ou MuYan Yan Chengyu, 63
Connected to:
Adela Liu, 73Alec X Liu, 39Alpha T Liu, 46Amon Y Liu, 58Andrea Y Liu, 46Anqi Liu, 39Arden K Liu, 64Ba S Liu, 62Bailu Liu, 35Ban Liu, 48

Wen Liu Phones & Addresses

  • 75 La Salle St APT 5E, New York, NY 10027 (646) 897-3589
  • 20 E Broadway FL 5, New York, NY 10002 (646) 613-0123
  • Woodhaven, NY
  • Brooklyn, NY
  • Flushing, NY
  • San Diego, CA
  • Florham Park, NJ

Professional Records

License Records

Wen Liu

License #:
04427 - Expired
Category:
Accountants
Issued Date:
Oct 1, 2008
Expiration Date:
Jun 30, 2009
Type:
Certified Public Accountant

Wen Liu

License #:
04427 - Expired
Category:
Accountants
Issued Date:
Oct 1, 2008
Expiration Date:
Jun 30, 2009
Type:
Certified Public Accountant

Wen Gao Liu

License #:
FMC00425 - Expired
Category:
Food Safety
Issued Date:
Jan 19, 1994
Expiration Date:
Jan 31, 2000
Type:
Certified Food Safety Mgr

Medicine Doctors

Wen Liu Photo 1

Wen Liu

View page
Specialties:
Internal Medicine
Work:
Wen Liu MD
8001 Youree Dr STE 880, Shreveport, LA 71115
(318) 798-3328 (phone), (318) 798-9729 (fax)

Pierremont Hospitalist Group
8001 Youree Dr STE 4007, Shreveport, LA 71115
(318) 212-3821 (phone), (318) 212-3825 (fax)
Education:
Medical School
Harbin Med Univ, Harbin City, Heilongjian, China
Graduated: 1984
Procedures:
Lumbar Puncture
Arthrocentesis
Cardiac Stress Test
Continuous EKG
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Skin Tags Removal
Vaccine Administration
Conditions:
Abdominal Hernia
Abnormal Vaginal Bleeding
Acne
Acute Conjunctivitis
Acute Myocardial Infarction (AMI)
Languages:
Chinese
English
Description:
Dr. Liu graduated from the Harbin Med Univ, Harbin City, Heilongjian, China in 1984. He works in Shreveport, LA and 1 other location and specializes in Internal Medicine. Dr. Liu is affiliated with Willis Knighton Pierremont Health Center.

Lawyers & Attorneys

Wen Liu Photo 2

Wen Liu - Lawyer

View page
ISLN:
1000698242
Admitted:
2013

Public records

Vehicle Records

Wen Liu

View page
Address:
14510 17 Rd, Whitestone, NY 11357
Phone:
(718) 767-8914
VIN:
2HNYD28227H518880
Make:
ACURA
Model:
MDX
Year:
2007

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wen Liu
CHARLENE INC
1807 Grv St, Ridgewood, NY 11385
PO Box 1002, Monterey Park, CA 91754
Wen Hung Liu
NO. 1 FORTUNE NAILS, INC
201 E 33 St, New York, NY 10016
Wen Jun Liu
MIN JUN CORP
3823 Ft Hamilton Pkwy, Brooklyn, NY 11218
Wen Li Liu
NING FA LI HOME IMPROVEMENT CORPORATION
79-20 Jamaica Ave, Woodhaven, NY 11421
Wen Liu
ABCMATH LEARNING CENTER INC
43-55 Kissena Blvd STE 1B, Flushing, NY 11355
Wen W Liu
NINO CLUB CORP
Nonclassifiable Establishments
353 Knickerbocker Ave, Brooklyn, NY 11237
46-09 102 St 1Fl, Corona, NY 11368
353 Knickerbocker Ave Ground, Brooklyn, NY 11237
Wen Liu
President,Secretary
WS INTERNATIONAL, INC
Wen Jian Liu
NEW MADISON SUPREME LAUNDROMAT INC
76-80 Madison St, New York, NY 10002

Publications

Us Patents

Cytoplasmic Activity Of Retinoid X Receptor And Its Regulation By Ligands And Dimerization

View page
US Patent:
8105798, Jan 31, 2012
Filed:
Aug 13, 2004
Appl. No.:
10/918116
Inventors:
Xihua Cao - San Diego CA, US
Wen Liu - San Diego CA, US
Assignee:
The Burnham Institute - La Jolla CA
International Classification:
G01N 33/53
US Classification:
435 78, 435 795
Abstract:
This invention relates to methods for identifying agents useful for treatment of diseases and pathological conditions affected by Retinoid X Receptor apoptosis. The invention also relates to methods for treating diseases and pathological conditions affected by RXR apoptosis. The invention includes compositions that are useful in the study and treatment of diseases and pathological conditions affected by RXR apoptosis.

Process For The Preparation Of An Isopropanol Solvate Of A Glucokinase Activator

View page
US Patent:
20070244129, Oct 18, 2007
Filed:
Apr 11, 2007
Appl. No.:
11/786269
Inventors:
Andrzej Robert Daniewski - Otrebusy, PL
Wen Liu - North Caldwell NJ, US
Roumen Nikolaev Radinov - West Caldwell NJ, US
International Classification:
A61K 31/4965
C07D 241/20
US Classification:
51425506, 544406
Abstract:
Provided is a process for the preparation of 2(R)-(3-Chloro-4-methanesulfonyl-phenyl)-3-((R)-3-oxo-cyclopentyl)-N-pyrazin-2-yl-propionamide and its isopropanol solvate as a glucokinase activator which increases insulin secretion in the treatment of, for example, type II diabetes.

Low Distortion Amplifier Circuit With Improved Output Power

View page
US Patent:
59173750, Jun 29, 1999
Filed:
Jun 2, 1997
Appl. No.:
8/867558
Inventors:
Richard Joseph Lisco - Whippany NJ
Wen Liu - Parsippany NJ
Jerrold Moravchik - Tenafly NJ
Assignee:
Lucent Technologies Inc. - Murray Hill NJ
International Classification:
H03F 126
US Classification:
330151
Abstract:
A low distortion amplifier circuit employing a main amplifier and a correction amplifier in a feed-forward loop, is particularly adapted for amplifying multi-tone signals. The main amplifier produces fundamental frequency power along with undesirable distortion products. The correction amplifier provides correction signals at the distortion product frequencies to cancel the distortion products of the main amplifier. In addition, the correction amplifier produces fundamental frequency power which is combined with the fundamental frequency power of the main amplifier, thereby increasing the amplifier circuit output power.

Methods And Compositions Related To Retinoid Receptor-Selective Pathway

View page
US Patent:
20170313668, Nov 2, 2017
Filed:
Feb 16, 2017
Appl. No.:
15/435125
Inventors:
- La Jolla CA, US
- Xiamen, CN
Hu ZHOU - San Diego CA, US
Wen LIU - La Jolla CA, US
Pei-Qiang HUANG - Xiamen, CN
International Classification:
C07D 295/112
C07C 57/62
C07C 59/72
A61K 38/19
C07C 255/57
C07D 213/55
G01N 33/50
Abstract:
Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenviroment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.

Methods And Compositions Related To A Retinoid Receptor-Selective Pathway

View page
US Patent:
20150266842, Sep 24, 2015
Filed:
May 6, 2011
Appl. No.:
13/102475
Inventors:
Ying Su - San Diego CA, US
Hu Zhou - San Diego CA, US
Wen Liu - La Jolla CA, US
Pei-Qiang Huang - Xiamen, CN
International Classification:
C07D 295/112
C07D 213/55
C07C 255/57
C07C 57/62
C07C 59/72
Abstract:
Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenvironment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.
Control profile
Wen S Liu from New York, NY, age ~58 Get Report